Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Grant/Award of 22,350 OKUR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 22,350 | n/a |
| Jun 18, 2026 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 22,195 | n/a |
| Jun 8, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 7,650 | n/a |
| Jun 9, 2025 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 6,682 | n/a |
| May 30, 2025 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 7,650 | n/a |
| Feb 10, 2025 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 20,491 | n/a |
| Oct 8, 2024 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 15,300 | n/a |
| Jun 7, 2024 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 7,688 | n/a |
| Feb 16, 2024 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 16,835 | n/a |
| Jun 12, 2023 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 11,297 | n/a |